过早动脉样硬化与单一性胰岛素耐药性相关
1John P. Robarts Research Institute, London, Ontario, Canada. robert.hegele@rri.on.ca
Circulation
|May 23, 2001
概括
导致家族局部脂质变异 (FPLD) 的罕见遗传突变与早期冠心病 (CHD) 有关,特别是在女性中. 这突出了FLPD作为理解常见胰岛素抵抗综合征及其心血管风险的模型.
科学领域:
- 遗传学和分子生物学
- 心血管疾病研究研究
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 胰岛素抵抗综合征的特点是肥胖,失脂症,高血糖症和高血压,增加了动脉样硬化风险.
- 早期动脉样硬化在罕见的单一性胰岛素抵抗形式中并没有得到充分的记录.
- 这项研究研究了因LMNA基因突变引起的Dunnigan型家族局部脂质变 (FPLD) 的心血管结果.
研究的目的:
- 为了评估Dunnigan型家族局部脂质变异 (FPLD) 的受试者心血管终点.
- 调查LMNA突变与早期发作的心血管疾病之间的联系.
- 确定FPLD是否可以作为常见胰岛素抵抗综合征的单一模型.
主要方法:
- 通过LMNA R482Q或R482W突变分层的FPLD受试者 (异合体载体和同合体对照) 进行了分析.
- 对代谢和心血管参数进行了检查,检查了基因型-表型相关性.
- 冠心病 (CHD) 事件在突变载体和对照对象之间进行了比较.
主要成果:
- 所有LMNA突变携带者都表现出具有胰岛素耐药性的FPLD.
- 与对照组相比,LMNA突变载体的2型糖尿病,高血压和脂质失调的发生率显著更高.
- 八名LMNA突变携带者患上冠心病 (CHD),其中六人在55岁之前发生了事件,其中包括四名为CABG手术住院的妇女在35-54岁之间.
结论:
- 导致FPLD的罕见LMNA突变与加速冠心病 (CHD) 相关,特别是在女性中.
- 在FPLD中核膜异常可以模仿常见的胰岛素抵抗综合征的关键特征,包括早发性心血管疾病.
- 家庭局部脂质缩症 (FPLD) 是一个有价值的人类单基因模型,用于研究常见的胰岛素抵抗综合征及其心血管并发症.
相关概念视频
Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...


